ALOX12 may indirectly contribute to blastogenesis suppression in patients with MDS, and how blastogenesis is inversely correlated with ALOX12 gene expression (see Figure 3E) should be further studied. The gene discussed is ALOX12; the disease is myelodysplastic syndrome.